Takeda Pharmaceutical (TAK) Property, Plant & Equipment (Net) (2017 - 2026)
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Property, Plant & Equipment (Net) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Property, Plant & Equipment (Net) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn | 23.58 Bn |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn | 5.80 Bn |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn | 25.74 Bn |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn | 10.69 Bn |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | 19.03 Bn |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | 113.37 Bn |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | 34.61 Mn |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 709.47 Mn |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn | 1.93 Bn |
| 10 | Takeda Pharmaceutical | 2.61 Bn | -3.18 Bn | 5.10 Bn | 13.44 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.44 Bn |
| Mar 31, 2026 | 13.52 Bn |
| Dec 31, 2025 | 13.54 Bn |
| Sep 30, 2025 | 13.47 Bn |
| Jun 30, 2025 | 13.52 Bn |
| Mar 31, 2025 | 12.90 Bn |
| Dec 31, 2024 | 13.27 Bn |
| Sep 30, 2024 | 12.65 Bn |
| Jun 30, 2024 | 13.40 Bn |
| Mar 31, 2024 | 13.43 Bn |
| Dec 31, 2023 | 12.46 Bn |
| Sep 30, 2023 | 13.12 Bn |
| Jun 30, 2023 | 13.10 Bn |
| Mar 31, 2023 | 12.79 Bn |
| Dec 31, 2022 | 11.72 Bn |
| Sep 30, 2022 | 12.75 Bn |
| Jun 30, 2022 | 13.19 Bn |
| Mar 31, 2022 | 13.62 Bn |
| Dec 31, 2021 | 13.14 Bn |
| Sep 30, 2021 | 13.26 Bn |